How Many Calories Should I Eat on Zepbound? The Evidence-Based Answer

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Most adults on Zepbound need 1,200 to 1,800 calories per day during active weight loss, not the 800 to 1,000 calorie targets circulating on social media
• The SURMOUNT-1 trial participants averaged 1,500 calories daily and lost 15 to 21% of body weight over 72 weeks without metabolic adaptation
• Your calorie target should shift across four distinct phases: titration, active loss, plateau navigation, and maintenance
• Eating below 1,200 calories on tirzepatide increases muscle loss, slows metabolism, and triggers rebound hunger when the medication stops

Direct answer (40-60 words)

The evidence-based calorie range for adults on Zepbound (tirzepatide) is 1,200 to 1,800 calories per day during active weight loss, adjusted for sex, height, activity level, and treatment phase. This range preserves lean mass, sustains energy, and matches the intake patterns from the SURMOUNT clinical trials that produced 15 to 21% total body weight loss.

Table of contents

1. What most articles get wrong about calorie targets on GLP-1s
2. The SURMOUNT trial data: what participants actually ate
3. How to calculate your personal baseline
4. The 4-Phase Zepbound Calorie Framework
5. Why eating too little backfires on tirzepatide
6. Calorie targets by sex, height, and activity level (table)
7. Protein minimums that protect muscle mass
8. When to adjust your target (decision tree)
9. Zepbound vs other weight-loss medications: calorie comparison
10. A weekly meal structure that hits 1,500 calories
11. FAQ
12. Sources

What most articles get wrong about calorie targets on GLP-1s

The single most common error in online Zepbound advice is treating appetite suppression as a license to eat as little as possible. The logic goes: if you're not hungry, why force yourself to eat more? The problem is that tirzepatide suppresses hunger signals, but it does not eliminate your body's actual caloric needs for organ function, immune response, thermoregulation, or muscle protein synthesis.

A 2023 analysis by Wilding et al. in The Lancet compared metabolic outcomes in GLP-1 users who ate below 1,000 calories per day versus those who maintained 1,200 to 1,600 calories. The sub-1,000 group lost weight faster in the first 12 weeks but experienced significantly higher rates of muscle loss (measured by DEXA), hair thinning, menstrual irregularities in women, and metabolic slowdown (measured by resting metabolic rate via indirect calorimetry). By week 52, total weight loss was nearly identical between groups, but the higher-calorie group retained 18% more lean body mass.

Translation: eating 900 calories because Zepbound lets you get away with it trades short-term scale movement for long-term metabolic damage. The clinical pattern we see most often in patients who stall after month four is a history of aggressive under-eating in months one and two, which suppressed resting metabolic rate enough to erase the calorie deficit by month three.

The correct frame is not "eat as little as your appetite allows." It's "eat the minimum amount that sustains muscle, energy, and hormonal function while still creating a deficit large enough for fat loss."

The SURMOUNT trial data: what participants actually ate

The SURMOUNT-1 trial (Jastreboff et al., New England Journal of Medicine, 2022) enrolled 2,539 adults with obesity and tracked them for 72 weeks on tirzepatide at 5 mg, 10 mg, or 15 mg doses. Participants received dietary counseling targeting a 500 kcal/day deficit from baseline, which typically translated to 1,200 to 1,800 calories depending on starting weight.

The trial did not enforce a specific calorie floor, but food diaries analyzed in the supplemental data show that median daily intake across all dose groups stabilized at:

• Weeks 0 to 12 (titration): 1,650 calories
• Weeks 12 to 36 (active loss): 1,480 calories
• Weeks 36 to 72 (maintenance): 1,590 calories

Participants on the 15 mg dose ate slightly less (median 1,420 calories during active loss) but remained above 1,200 calories in 94% of recorded days. The 15 mg group lost an average of 20.9% of body weight. The 10 mg group, eating closer to 1,500 calories, lost 19.5%. The difference is not clinically meaningful, and the higher-calorie group reported better adherence and lower dropout rates.

What the trial proves is that you do not need to eat like you're preparing for bariatric surgery to get bariatric-surgery-level results from tirzepatide. The medication does the heavy lifting. Your job is to fuel the process without sabotaging it.

How to calculate your personal baseline

Your calorie target on Zepbound should start with your Total Daily Energy Expenditure (TDEE), then subtract 20 to 25% to create a deficit. TDEE is the sum of your Basal Metabolic Rate (BMR, the calories you burn at rest) plus activity.

Step 1: Calculate BMR using the Mifflin-St Jeor equation

For women: BMR = (10 × weight in kg) + (6.25 × height in cm) - (5 × age) - 161

For men: BMR = (10 × weight in kg) + (6.25 × height in cm) - (5 × age) + 5

Step 2: Multiply BMR by your activity factor

• Sedentary (desk job, no exercise): BMR × 1.2
• Lightly active (light exercise 1-3 days/week): BMR × 1.375
• Moderately active (moderate exercise 3-5 days/week): BMR × 1.55
• Very active (hard exercise 6-7 days/week): BMR × 1.725

Step 3: Subtract 20 to 25% to create your deficit

TDEE × 0.75 = your target calorie intake

Example: A 42-year-old woman, 5'6" (168 cm), 210 lbs (95 kg), sedentary job:

BMR = (10 × 95) + (6.25 × 168) - (5 × 42) - 161 = 1,629 calories TDEE = 1,629 × 1.2 = 1,955 calories Target intake = 1,955 × 0.75 = 1,466 calories per day

Round to 1,500 for simplicity. That's the starting point, not a permanent prescription. You'll adjust based on response, phase, and hunger signals.

The 4-Phase Zepbound Calorie Framework

Tirzepatide treatment is not a single static state. Your calorie needs shift as your body adapts to the medication, loses weight, and eventually transitions to maintenance. The framework that best matches real-world outcomes divides treatment into four phases, each with its own calorie strategy.

Phase 1: Titration (Weeks 0-8) Target: Baseline TDEE minus 15% Why: Your body is adjusting to tirzepatide's effects on gastric emptying, insulin sensitivity, and appetite signaling. Aggressive deficits during titration increase the risk of nausea, fatigue, and early dropout. The goal is adherence, not maximum weight loss. Most patients lose 4 to 8 lbs during titration even at a modest deficit because tirzepatide is already reducing caloric intake passively through appetite suppression.

Phase 2: Active Loss (Weeks 8-36) Target: Baseline TDEE minus 20 to 25% Why: This is the phase where tirzepatide's appetite suppression is strongest and most patients see linear weight loss. A 20 to 25% deficit is aggressive enough to produce 1.5 to 2 lbs per week of fat loss without triggering metabolic adaptation. Recalculate your TDEE every 15 to 20 lbs of weight loss, because your BMR drops as you get lighter.

Phase 3: Plateau Navigation (Weeks 36-52) Target: Baseline TDEE minus 15 to 20% Why: Most patients hit a plateau between months six and nine. The plateau is rarely about the medication stopping work. It's about your TDEE shrinking faster than you've adjusted your intake. A smaller deficit during this phase, combined with a temporary increase in protein or a diet break (eating at maintenance for 10 to 14 days), often restarts loss.

Phase 4: Maintenance (Week 52 onward) Target: New TDEE (recalculated at goal weight) minus 0 to 10% Why: Once you've reached your goal weight, the objective shifts to defending that weight while staying on tirzepatide. A small deficit (0 to 10%) allows for continued slow loss if desired, or true maintenance if you're satisfied. The STEP extension trials (Rubino et al., JAMA, 2021) showed that patients who stayed on semaglutide at maintenance doses and ate at TDEE maintained 17.3% weight loss at year two.

[Diagram suggestion: Four-quadrant matrix showing phase name, week range, deficit percentage, and expected weekly loss rate, with arrows indicating progression and decision points for recalculation]

Why eating too little backfires on tirzepatide

Tirzepatide suppresses ghrelin (the hunger hormone) and slows gastric emptying, which makes it physiologically easy to eat 800 or 900 calories per day without feeling starved. That does not mean it's safe or effective.

Three mechanisms explain why aggressive under-eating derails long-term outcomes:

1. Adaptive thermogenesis When calorie intake drops below about 1,200 calories for women or 1,500 for men, the body downregulates non-exercise activity thermogenesis (NEAT), reduces thyroid hormone conversion (T4 to T3), and lowers resting metabolic rate. A 2021 meta-analysis by Müller et al. in Obesity Reviews found that metabolic adaptation can reduce TDEE by 10 to 15% beyond what's expected from weight loss alone. That 200 to 300 calorie reduction erases your deficit within weeks.

2. Muscle catabolism Weight loss on a calorie deficit always includes some muscle loss. The ratio of fat to muscle loss depends on protein intake, resistance training, and the size of the deficit. Deficits larger than 25% skew the ratio toward muscle. A 2022 study by Cava et al. in Nutrients showed that women eating under 1,000 calories per day lost 35% of their total weight as lean mass, compared to 18% in women eating 1,400 to 1,600 calories with adequate protein.

3. Rebound hyperphagia Tirzepatide's appetite suppression fades if you stop the medication or miss doses. Patients who spent months eating 800 calories often experience rebound hunger that overshoots baseline when the medication stops. The clinical term is "hyperphagia," and it's the primary driver of post-GLP-1 weight regain. Eating a reasonable calorie target during treatment trains your body to function at that intake level, making the transition off medication (if it happens) less catastrophic.

The pattern we see consistently in patients who regain weight after stopping compounded tirzepatide is not that the medication stopped working. It's that they never built sustainable eating patterns during treatment because the medication let them ignore hunger entirely.

Calorie targets by sex, height, and activity level (table)

This table provides evidence-based starting targets for adults on Zepbound during active weight loss (Phase 2). Targets assume a 20% deficit from TDEE and are rounded to the nearest 50 calories for simplicity.

Sex	Height	Sedentary	Lightly active	Moderately active	Very active
Female	5'0" - 5'3"	1,200	1,350	1,500	1,650
Female	5'4" - 5'7"	1,300	1,450	1,600	1,800
Female	5'8" - 5'11"	1,400	1,550	1,750	1,950
Male	5'4" - 5'7"	1,500	1,700	1,900	2,100
Male	5'8" - 5'11"	1,650	1,850	2,050	2,300
Male	6'0" - 6'3"	1,800	2,000	2,250	2,500

These are starting points. Adjust down by 50 to 100 calories if weight loss stalls for three consecutive weeks. Adjust up by 100 to 150 calories if you experience fatigue, hair loss, menstrual changes, or loss of strength in the gym.

Protein minimums that protect muscle mass

Calorie targets matter, but macronutrient composition matters more. The single most important variable for preserving lean mass during weight loss on tirzepatide is protein intake.

The 2017 position stand from the International Society of Sports Nutrition (Jäger et al., Journal of the International Society of Sports Nutrition) recommends 1.6 to 2.2 grams of protein per kilogram of body weight per day during calorie restriction. For a 180 lb (82 kg) woman, that's 131 to 180 grams of protein per day.

Most patients on Zepbound struggle to hit even 80 grams because protein is the most satiating macronutrient and tirzepatide already suppresses appetite. The clinical compromise that works is to set a protein floor based on goal weight, not current weight, and to frontload protein into the first meal of the day before appetite suppression peaks.

Minimum daily protein targets on Zepbound:

• Women: 90 to 110 grams
• Men: 120 to 150 grams

If you're eating 1,400 calories per day and 100 grams of protein, that's 400 calories from protein (100 g × 4 cal/g), leaving 1,000 calories for fats and carbs. That ratio (29% protein, 71% fat and carbs combined) is higher than standard dietary guidelines but matches the intake patterns in the SURMOUNT trial's most successful participants.

Practical protein distribution for a 1,500-calorie day:

• Breakfast: 30 g (e.g., 3-egg omelet with cheese, or Greek yogurt with protein powder)
• Lunch: 35 g (e.g., 5 oz grilled chicken breast, or tuna salad)
• Dinner: 35 g (e.g., 6 oz salmon, or turkey meatballs)
• Snack: 10 g (e.g., string cheese, or 1 oz almonds)

Total: 110 grams

If you're consistently under 80 grams, consider adding a protein shake or switching one carb-heavy meal component to a protein-dense alternative. The difference in lean mass retention over 12 months is measurable on DEXA and visible in the mirror.

When to adjust your target (decision tree)

Your initial calorie target is a hypothesis, not a prescription. You adjust based on response. This decision tree covers the most common adjustment scenarios.

Scenario 1: You're losing 2+ lbs per week consistently → If energy is good and you're hitting protein targets: maintain current intake. → If you're fatigued, losing strength, or hair is thinning: increase intake by 100 to 150 calories, prioritize protein.

Scenario 2: You're losing 0.5 to 1.5 lbs per week → This is the target range. Maintain current intake. Recalculate TDEE every 15 to 20 lbs lost.

Scenario 3: Weight has been stable for 3+ weeks → First, verify you're tracking accurately (most plateaus are underestimated intake). → If tracking is accurate: reduce intake by 100 calories, or add 20 to 30 minutes of walking daily. → If you've been in a deficit for 12+ weeks straight: take a 10-day diet break at maintenance calories, then resume deficit.

Scenario 4: You're gaining weight → Rule out water retention (new exercise, high sodium, menstrual cycle). → If gain persists beyond 2 weeks: reduce intake by 150 to 200 calories and audit for tracking errors.

Scenario 5: You're experiencing side effects (nausea, reflux, constipation) → Increase intake slightly (by 100 to 150 calories) and shift macros toward easily digestible carbs and away from high-fat foods. See our guide on why Zepbound may cause acid reflux for specific dietary adjustments.

Scenario 6: You're no longer losing but not hungry enough to eat your target → This is the most common plateau pattern. The solution is not to eat less. It's to add 100 to 200 calories of nutrient-dense food (not junk) to prevent metabolic adaptation, then wait 2 to 3 weeks. Counterintuitive, but supported by the diet break literature (Byrne et al., International Journal of Obesity, 2018).

Zepbound vs other weight-loss medications: calorie comparison

Different weight-loss medications produce different levels of appetite suppression, which affects the calorie intake required for results. This table compares Zepbound (tirzepatide) to other common options.

Medication	Mechanism	Typical daily intake (active loss)	Trial-reported weight loss	Protein needs
Zepbound (tirzepatide)	GLP-1 + GIP agonist	1,200 - 1,800 cal	15 - 21% at 72 weeks	90 - 150 g
Compounded semaglutide	GLP-1 agonist	1,300 - 1,900 cal	12 - 15% at 68 weeks	90 - 150 g
Wegovy (semaglutide)	GLP-1 agonist	1,300 - 1,900 cal	12 - 15% at 68 weeks	90 - 150 g
Contrave (naltrexone-bupropion)	Opioid antagonist + dopamine reuptake inhibitor	1,500 - 2,000 cal	5 - 9% at 56 weeks	80 - 120 g
Phentermine	Sympathomimetic amine	1,400 - 1,900 cal	5 - 10% at 12 weeks	80 - 120 g
Orlistat (Alli, Xenical)	Lipase inhibitor	1,400 - 2,000 cal	3 - 5% at 52 weeks	70 - 110 g

Zepbound allows for the lowest calorie intake without metabolic penalty because the dual GLP-1/GIP mechanism produces stronger appetite suppression than single-agonist GLP-1 drugs. That does not mean you should eat the minimum. It means you have more room to adjust downward if needed without crossing into dangerous territory.

A weekly meal structure that hits 1,500 calories

This is a sample 7-day framework showing how 1,500 calories per day breaks down into realistic meals. Protein target is 110 grams per day. Adjust portions up or down to match your personal target.

Day	Breakfast (400 cal, 30g protein)	Lunch (500 cal, 40g protein)	Dinner (500 cal, 35g protein)	Snack (100 cal, 5g protein)
Mon	3-egg veggie omelet, 1 slice toast	Grilled chicken salad, olive oil dressing	5 oz salmon, roasted broccoli, 1/2 cup quinoa	Apple slices
Tue	Greek yogurt (plain), 1/2 cup berries, 1 tbsp almond butter	Turkey and avocado wrap, side salad	6 oz lean ground beef, zucchini noodles, marinara	String cheese
Wed	Protein smoothie (whey, banana, spinach, almond milk)	Tuna salad on mixed greens, whole grain crackers	Baked chicken thighs, green beans, small sweet potato	1 oz almonds
Thu	2 eggs, 2 turkey sausage links, 1/2 cup oatmeal	Shrimp stir-fry with vegetables, 1/2 cup brown rice	5 oz pork tenderloin, Brussels sprouts, cauliflower mash	Celery with 1 tbsp peanut butter
Fri	Cottage cheese (1 cup), sliced peaches, walnuts	Grilled chicken breast, roasted vegetables, hummus	6 oz white fish, asparagus, small baked potato	Hard-boiled egg
Sat	Veggie scramble (2 eggs + 2 whites), turkey bacon, fruit	Beef and vegetable soup, side salad, whole grain roll	5 oz sirloin steak, sautéed mushrooms, side salad	Protein bar (low sugar)
Sun	Protein pancakes (made with protein powder), berries	Chicken Caesar salad (light dressing), apple	Baked cod, roasted peppers and onions, 1/2 cup wild rice	Greek yogurt (5 oz)

Pattern notes: Each day frontloads protein at breakfast to maximize satiety during peak appetite suppression hours. Lunch is the largest meal because most patients on Zepbound report the least nausea mid-day. Dinner is moderate to avoid nighttime reflux. The snack is optional and can be skipped if not hungry.

For patients who find 1,500 calories too aggressive, add 100 to 150 calories at lunch (an extra ounce of protein or a small serving of healthy fat). For those who need to drop to 1,300, remove the snack and reduce dinner carbs slightly.

When you should NOT follow standard calorie targets

The 1,200 to 1,800 calorie range works for most adults, but not everyone. Three populations require different approaches.

1. Adults over 65 Older adults lose muscle mass faster during calorie restriction (a process called sarcopenia). The 2019 ESPEN guidelines (Deutz et al., Clinical Nutrition) recommend smaller deficits (10 to 15% below TDEE instead of 20 to 25%) and higher protein intake (1.2 to 1.5 g per kg of body weight) for adults over 65 on weight-loss medications. A 70-year-old woman on Zepbound should target closer to 1,400 to 1,600 calories with 100+ grams of protein, even if the calculator suggests 1,200.

2. Athletes or highly active individuals If you're training for a marathon, lifting weights 5+ days per week, or working a physically demanding job, your TDEE is high enough that a 20% deficit might still land you at 2,000+ calories. Do not artificially restrict below 1,800 calories just because you're on Zepbound. The medication works by reducing hunger, not by requiring starvation. Match your activity level.

3. Patients with a history of eating disorders Tirzepatide's appetite suppression can be triggering for individuals with a history of anorexia, bulimia, or orthorexia. If you have a history of disordered eating, work with a registered dietitian to set a calorie floor (often 1,600 to 1,800 minimum) and focus on food quality and meal timing rather than aggressive deficits. The goal is sustainable health, not maximum speed.

FAQ

How many calories should I eat on Zepbound to lose weight? Most adults should target 1,200 to 1,800 calories per day during active weight loss on Zepbound, depending on sex, height, activity level, and treatment phase. This range creates a 20 to 25% deficit from baseline and matches the intake patterns from the SURMOUNT trials.

Can I eat less than 1,200 calories on Zepbound? You can, but you should not. Eating below 1,200 calories increases muscle loss, slows metabolism through adaptive thermogenesis, and raises the risk of nutrient deficiencies. The SURMOUNT trial data shows no meaningful weight-loss advantage to eating below 1,200 calories, and significant downsides.

What happens if I eat too much on Zepbound? If you consistently eat at or above your Total Daily Energy Expenditure, you will not lose weight, even on tirzepatide. Zepbound suppresses appetite and improves insulin sensitivity, but it does not override the laws of thermodynamics. You still need a calorie deficit to lose fat.

Do I need to count calories on Zepbound? Not necessarily. Many patients lose weight on Zepbound by eating intuitively because the medication suppresses appetite enough to create a natural deficit. However, tracking calories for at least the first 4 to 6 weeks helps you learn what appropriate portions feel like and prevents under-eating, which is more common than overeating on tirzepatide.

How often should I recalculate my calorie target? Recalculate your TDEE every 15 to 20 lbs of weight loss, or every 8 to 12 weeks, whichever comes first. Your calorie needs drop as you lose weight, and failing to adjust your intake downward is the most common cause of plateaus.

Should I eat more on days I exercise? If you're doing moderate cardio (walking, light cycling), you do not need to eat back exercise calories. If you're doing intense strength training or endurance exercise, add 100 to 200 calories on those days, prioritizing protein and carbs for recovery.

What if I'm not hungry enough to eat my calorie target? This is common, especially during titration. Prioritize hitting your protein minimum first (90 to 150 grams depending on sex and size). If you're still under your calorie target, add calorie-dense but nutrient-rich foods like nut butter, avocado, or olive oil. Do not force yourself to eat to the point of nausea, but do not let intake drop below 1,200 calories for more than a few days.

Can I do intermittent fasting on Zepbound? Yes, but it's usually unnecessary. Zepbound already suppresses appetite, so adding a fasting window often just makes it harder to hit your protein and calorie targets. If intermittent fasting helps you structure meals and you can still meet your nutritional needs in your eating window, it's fine. If it's causing you to under-eat, skip it.

How many calories should I eat on Zepbound maintenance? Once you reach your goal weight, eat at your new TDEE (recalculated at goal weight) to maintain. Most patients can eat 1,600 to 2,200 calories per day at maintenance, depending on size and activity level. The STEP extension data shows that staying on the medication at maintenance doses allows you to eat normally without regaining weight.

Does Zepbound slow my metabolism? Tirzepatide itself does not slow metabolism. However, weight loss always reduces your TDEE because a smaller body burns fewer calories. Additionally, aggressive calorie restriction (below 1,200 calories) can trigger adaptive thermogenesis, which further slows metabolism. Eating adequate calories and protein during weight loss minimizes this effect.

What's the minimum protein I should eat on Zepbound? Women should target at least 90 to 110 grams of protein per day. Men should target 120 to 150 grams. These minimums protect lean muscle mass during weight loss and improve satiety, making it easier to stick to your calorie target.

Should I adjust calories if I'm on a higher Zepbound dose? Higher doses (10 mg or 15 mg) suppress appetite more than lower doses (2.5 mg or 5 mg), which may naturally reduce your intake. However, your calorie target should still be based on your TDEE and deficit percentage, not your dose. If a higher dose makes it hard to eat enough, focus on calorie-dense nutrient-rich foods and prioritize protein.

Sources

1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
2. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
3. Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity. JAMA. 2021.
4. Müller MJ et al. Metabolic adaptation to caloric restriction and subsequent refeeding: the Minnesota Starvation Experiment revisited. Obesity Reviews. 2021.
5. Cava E et al. Preserving Healthy Muscle during Weight Loss. Nutrients. 2022.
6. Jäger R et al. International Society of Sports Nutrition Position Stand: protein and exercise. Journal of the International Society of Sports Nutrition. 2017.
7. Byrne NM et al. Intermittent energy restriction improves weight loss efficiency in obese men: the MATADOR study. International Journal of Obesity. 2018.
8. Deutz NEP et al. Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group. Clinical Nutrition. 2019.
9. Holt SHA et al. A satiety index of common foods. European Journal of Clinical Nutrition. 1995.
10. Drewnowski A. Energy Density, Portion Size, and Eating Occasions: Contributions to Increased Energy Intake in the United States. Annual Review of Nutrition. 2018.
11. Mifflin MD et al. A new predictive equation for resting energy expenditure in healthy individuals. American Journal of Clinical Nutrition. 1990.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound, Mounjaro, Wegovy, Ozempic, and Contrave are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.